Beyond efficacy alone, as the obesity treatment market continues to grow and competition intensifies, there will likely be an increasing focus on accessibility, affordability and long-term patient adherence
Siavoshi defines a microdose as the lowest dose of a GLP-1 that lowers food noise without causing any significant weight loss. Food noise, a term used in obesity medicine, refers to chronic unwanted thoughts that make healthful choices (both about how much to eat and what to eat) difficult
We also know that discontinuing any weight loss strategy, including GLPs, can result in weight regain - and often it's not muscle you're gaining back
Moreover, GLP-1RAs have cognition-promoting effects and activate the GLP-1R/cAMP/PKA pathway, thus providing a new intervention for the treatment of depression and reduction of SSIBs [36, 47, 48]